Fortress Biotech, Inc.
FBIOP
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dā¦ read more
Healthcare
Biotechnology
8 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$18.30
Price+0.17%
$0.03
1Y
Price
Market Cap
$144.063m
Small
Price/Earnings 3y Avg5y Avg
9.4x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+918.8%
EBITDA Margin+688.2%
Net Profit Margin+1271.1%
Free Cash Flow Margin+918.8%
EBITDA Margin+688.2%
Net Profit Margin+1271.1%
Free Cash Flow MarginRevenue
$66.161m
+4.6%
1y CAGR-5.8%
3y CAGR-1.5%
5y CAGREarnings
$127.772m
+1774.9%
1y CAGR+637.9%
3y CAGR+486.0%
5y CAGREPS
$3.18
+4642.9%
1y CAGR+1602.8%
3y CAGR+1212.6%
5y CAGRBook Value
$202.374m
$356.874m
Assets$154.500m
Liabilities$53.627m
DebtDebt to Assets
15.0%
0.4x
Debt to EBITDAFree Cash Flow
$157.637m
+339.7%
1y CAGR+133.6%
3y CAGR+106.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company